公开(公告)号：US20100120902A1

公开(公告)日：2010-05-13

申请号：US12532815

申请日：2008-03-24

Applicant: Chandra Kant Katiyar ,  Anil Kanaujia ,  Rajeev Duggar ,  Satyapal Singh Yadav ,  Navin Sharma ,  Abhijit Ray ,  Rajkumar Shirumalla ,  Malini Bajpai ,  Gyanesh Shukla ,  Baddireddi Subhadra Lakshmi ,  Kontham Sanathkumar Vinaykumar

Inventor： Chandra Kant Katiyar ,  Anil Kanaujia ,  Rajeev Duggar ,  Satyapal Singh Yadav ,  Navin Sharma ,  Abhijit Ray ,  Rajkumar Shirumalla ,  Malini Bajpai ,  Gyanesh Shukla ,  Baddireddi Subhadra Lakshmi ,  Kontham Sanathkumar Vinaykumar

IPC: A61K31/352 ,  A61P29/00 ,  A61P19/02 ,  A61P19/00

CPC classification number: A61K36/185

Abstract: The present invention relates to standardized extracts of Boerhaavia diffusa, wherein the extracts have anti inflammatory and analgesic activities. The present invention also includes bioassay guided fractionation of Boerhaavia diffusa leading to the identification of bioactive markers; processes for the isolation of the bioactive markers; processes for the preparation of the extracts enriched with bioactive markers from Boerhaavia diffusa; pharmaceutical compositions comprising bioactive markers, or standardized extracts of Boerhaavia diffusa and methods of standardization of the extracts.

Abstract translation: 本发明涉及双歧杆菌的标准化提取物，其中提取物具有抗炎和止痛活性。 本发明还包括生物测定引导分离的Boerhaavia diffusa，导致鉴定生物活性标记; 分离生物活性标记物的方法; 用于制备富含Boerhaavia diffusa的生物活性标记物的提取物的方法; 包含生物活性标记物或Boerhaavia diffusa的标准化提取物的药物组合物和提取物的标准化方法。